Does feel like deja vu - but again like last time, the data needs to be double checked - too much riding on it.
Could be bad, could be good. Either way, extreme scrutiny needed - last think RAP want to do is make a very Pos ann - only to find there is some flaw (or potential for misintepretation) in the findings. Remember they will want to move on directly to FDA approval, so results must be firefproof
Also purges all open orders.
Ann: Voluntary Suspension, page-23
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #